Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANZUWNASDAQ:ATAKWNASDAQ:DRTSWNASDAQ:TLSIW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANZUWAnzu Special Acquisition Corp I$0.06+8.5%$0.04$0.00▼$0.15N/AN/A32,101 shs171 shsATAKWAurora Technology Acquisition$0.01-8.0%$0.01$0.01▼$0.04N/AN/A85,679 shs45,958 shsDRTSWAlpha Tau Medical$0.22+2.4%$0.22$0.09▼$0.50N/AN/A29,687 shs100 shsTLSIWTriSalus Life Sciences$1.28-34.4%$1.37$0.42▼$2.49N/AN/A4,850 shs424 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANZUWAnzu Special Acquisition Corp I0.00%+0.46%+56.76%+82.30%+30.58%ATAKWAurora Technology Acquisition0.00%-1.32%-1.32%-23.20%-51.31%DRTSWAlpha Tau Medical-1.87%-15.97%+16.67%-22.22%-12.50%TLSIWTriSalus Life Sciences+21.88%+21.88%+89.32%+29.14%-1.02%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/AN/AN/ATLSIWTriSalus Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANZUWAnzu Special Acquisition Corp I 0.00N/AN/AN/AATAKWAurora Technology Acquisition 0.00N/AN/AN/ADRTSWAlpha Tau Medical 0.00N/AN/AN/ATLSIWTriSalus Life Sciences 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/AN/ATLSIWTriSalus Life Sciences$32.14MN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANZUWAnzu Special Acquisition Corp IN/AN/A0.00∞N/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/A0.00∞N/AN/AN/AN/AN/ATLSIWTriSalus Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANZUWAnzu Special Acquisition Corp IN/AN/AN/AN/AN/AATAKWAurora Technology AcquisitionN/AN/AN/AN/AN/ADRTSWAlpha Tau MedicalN/AN/AN/AN/AN/ATLSIWTriSalus Life SciencesN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANZUWAnzu Special Acquisition Corp IN/AATAKWAurora Technology AcquisitionN/ADRTSWAlpha Tau MedicalN/ATLSIWTriSalus Life SciencesN/AInsider OwnershipCompanyInsider OwnershipANZUWAnzu Special Acquisition Corp IN/AATAKWAurora Technology AcquisitionN/ADRTSWAlpha Tau MedicalN/ATLSIWTriSalus Life SciencesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANZUWAnzu Special Acquisition Corp I2N/AN/ANot OptionableATAKWAurora Technology AcquisitionN/AN/AN/ANot OptionableDRTSWAlpha Tau Medical80N/AN/ANot OptionableTLSIWTriSalus Life Sciences106N/AN/ANot OptionableTLSIW, DRTSW, ANZUW, and ATAKW HeadlinesRecent News About These CompaniesTriSalus Life Sciences names new CFOJune 2 at 10:38 AM | bizwest.comTriSalus Names David Patience Finance Chief as James Young DepartsMay 30, 2025 | marketwatch.comTriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comTriSalus Life Sciences Inc (TLSI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...May 16, 2025 | finance.yahoo.comTriSalus Life Sciences (TLSI) Gets a Buy from JonesTradingApril 26, 2025 | markets.businessinsider.comTriSalus Life Sciences files to offer up to 3.34M sharesApril 26, 2025 | msn.comTriSalus Life Sciences files to sell 91,263 shares of common stock for holdersApril 26, 2025 | markets.businessinsider.comTriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | insidermonkey.comAnalysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Beta Bionics, Inc. (BBNX)March 27, 2025 | markets.businessinsider.com4TLSI : Examining the Future: TriSalus Life Sciences's Earnings OutlookMarch 26, 2025 | benzinga.comTriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System MappingMarch 26, 2025 | finance.yahoo.comLake Street Initiates Coverage of TriSalus Life Sciences (TLSI) with Buy RecommendationFebruary 14, 2025 | msn.comTriSalus Life Sciences Announces Key Appointments to Board of DirectorsFebruary 3, 2025 | finance.yahoo.comTriSalus Life Sciences bolsters board with two new membersFebruary 3, 2025 | msn.comTriSalus Life Sciences expands board, appoints new directorsFebruary 2, 2025 | msn.comTrisalus life sciences CEO buys $50,302 in stockJanuary 30, 2025 | msn.comTrisalus life sciences director Sean Murphy buys $157,200 in stockJanuary 30, 2025 | msn.comAnalysts Are Bullish on Top Healthcare Stocks: Align Tech (ALGN), TriSalus Life Sciences (TLSI)January 24, 2025 | markets.businessinsider.comTriSalus Life Sciences sees Q4 revenue $8.3M, consensus $8.04MJanuary 23, 2025 | markets.businessinsider.comRoth expects ‘continued strong execution’ from TriSalus under new CFOJanuary 10, 2025 | markets.businessinsider.comMedia Sentiment Over TimeTLSIW, DRTSW, ANZUW, and ATAKW Company DescriptionsAnzu Special Acquisition Corp I NASDAQ:ANZUW$0.06 +0.01 (+8.53%) As of 05/30/2025Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Aurora Technology Acquisition NASDAQ:ATAKW$0.01 0.00 (-8.02%) As of 05/30/2025Aurora Technology Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on businesses in the technology companies, including artificial intelligence, blockchain, quantum computing, and electric vehicles in Asia and North America. The company was incorporated in 2021 and is based in San Francisco, California.Alpha Tau Medical NASDAQ:DRTSW$0.22 +0.01 (+2.38%) As of 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.TriSalus Life Sciences NASDAQ:TLSIW$1.28 -0.67 (-34.35%) As of 03:33 PM EasternTriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Qualcomm: A Technical Deep-Dive Confirms the Worst Rocket Lab Expands Into Payloads: Should You Be Paying Attention? Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Broadcom Earnings Preview: AVGO Stock Near Record Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
